Paper33449342
Towards the use of localised delivery strategies to counteract cancer therapy-induced cardiotoxicities.
Monahan DS and 5 others. Drug Deliv Transl Res, 2021. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Towards the use of localised delivery strategies to counteract cancer therapy-induced cardiotoxicities. Papers, record 33449342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33449342
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Towards the use of localised delivery strategies to counteract cancer therapy-induced cardiotoxicities.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Heart Failure | Major topic |
| Neoplasms | Major topic |
| Cardiotoxicity | |
| Humans | |
| Immunotherapy |
Source PubMed
References132
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7707129 | Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. | J Clin Oncol | 1995 | https://conductscience.org/library/papers/7707129 | PubMed |
| 2 | 24804274 | The PEG-PCL-PEG Hydrogel as an Implanted Ophthalmic Delivery System after Glaucoma Filtration Surgery; a Pilot Study. | Med Hypothesis Discov Innov Ophthalmol | 2014 | https://conductscience.org/library/papers/24804274 | PubMed |
| 3 | 25889431 | SIRT1 activation rescues doxorubicin-induced loss of functional competence of human cardiac progenitor cells. | Int J Cardiol | 2015 | https://conductscience.org/library/papers/25889431 | PubMed |
| 4 | 29536852 | Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis. | Lancet | 2018 | https://conductscience.org/library/papers/29536852 | PubMed |
| 5 | 29567210 | Myocarditis in Patients Treated With Immune Checkpoint Inhibitors. | J Am Coll Cardiol | 2018 | https://conductscience.org/library/papers/29567210 | PubMed |
| 6 | 28890351 | In situ delivery and production system of trastuzumab scFv with Bifidobacterium. | Biochem Biophys Res Commun | 2017 | https://conductscience.org/library/papers/28890351 | PubMed |
| 7 | 27667179 | Ultrasound-triggered drug delivery for cancer treatment using drug delivery systems: From theoretical considerations to practical applications. | J Control Release | 2016 | https://conductscience.org/library/papers/27667179 | PubMed |
| 8 | 23598172 | Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial. | Lancet Oncol | 2013 | https://conductscience.org/library/papers/23598172 | PubMed |
| 9 | 24125490 | Thermoresponsive polymers as gene and drug delivery vectors: architecture and mechanism of action. | Expert Opin Drug Deliv | 2013 | https://conductscience.org/library/papers/24125490 | PubMed |
| 10 | 17683255 | Recombinant human hyaluronidase (rHuPH20): an enabling platform for subcutaneous drug and fluid administration. | Expert Opin Drug Deliv | 2007 | https://conductscience.org/library/papers/17683255 | PubMed |
| 11 | 23169518 | High-dose vincristine sulfate liposome injection for advanced, relapsed, and refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia. | J Clin Oncol | 2013 | https://conductscience.org/library/papers/23169518 | PubMed |
| 12 | 25727219 | Novel delivery methods bypassing the blood-brain and blood-tumor barriers. | Neurosurg Focus | 2015 | https://conductscience.org/library/papers/25727219 | PubMed |
| 13 | 30062173 | A Minimally Invasive, Translational Method to Deliver Hydrogels to the Heart Through the Pericardial Space. | JACC Basic Transl Sci | 2017 | https://conductscience.org/library/papers/30062173 | PubMed |
| 14 | 23964934 | Pazopanib versus sunitinib in metastatic renal-cell carcinoma. | N Engl J Med | 2013 | https://conductscience.org/library/papers/23964934 | PubMed |
| 15 | 25451966 | Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases. | Biochim Biophys Acta | 2015 | https://conductscience.org/library/papers/25451966 | PubMed |
| 16 | 26780173 | Arming embolic beads with anti-VEGF antibodies and controlling their release using LbL technology. | J Control Release | 2016 | https://conductscience.org/library/papers/26780173 | PubMed |
| 17 | 27057439 | Hydrogel dual delivered celecoxib and anti-PD-1 synergistically improve antitumor immunity. | Oncoimmunology | 2016 | https://conductscience.org/library/papers/27057439 | PubMed |
| 18 | 20728697 | Mechanisms of anthracycline cardiac injury: can we identify strategies for cardioprotection? | Prog Cardiovasc Dis | 2010 | https://conductscience.org/library/papers/20728697 | PubMed |
| 19 | 15860848 | Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity. | J Clin Oncol | 2005 | https://conductscience.org/library/papers/15860848 | PubMed |
| 20 | 27349465 | Temperature-Responsive Smart Nanocarriers for Delivery Of Therapeutic Agents: Applications and Recent Advances. | ACS Appl Mater Interfaces | 2016 | https://conductscience.org/library/papers/27349465 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36671774 | Nanoparticle Based Cardiac Specific Drug Delivery. | Biology (Basel) | 2023 | https://conductscience.org/library/papers/36671774 | PubMed |
| 34885888 | The Implication of Low Dose Dimethyl Sulfoxide on Mitochondrial Function and Oxidative Damage in Cultured Cardiac and Cancer Cells. | Molecules | 2021 | https://conductscience.org/library/papers/34885888 | PubMed |
| 34277738 | Nanomedicine in Oncocardiology: Contribution and Perspectives of Preclinical Studies. | Front Cardiovasc Med | 2021 | https://conductscience.org/library/papers/34277738 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33449342
GET https://conductscience.org/api/papers/v1/33449342/references?page=2